Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Valitas Ventures is an Evergreen partnership founded in Israel, focusing on health technology investments. Established to leverage the strengths of the Israeli healthcare system, Valitas Ventures targets companies that have completed scientific feasibility stages or are in advanced regulatory phases. The firm aims to enhance the value of its portfolio companies, a strategy that gained recognition during the COVID-19 pandemic.
Currently based in Herzliya, Valitas Ventures operates primarily in North America and Europe, investing in health technology firms transitioning from development to commercialization. The firm has not publicly disclosed its fund size or total assets under management, but it is known for its specialized approach to health technology investments.
Valitas Ventures has a portfolio that includes companies like FIZE Medical, which raised $30 million in Series A funding, and Profility, a digital health company. The firm’s unique model facilitates rapid transitions from development to commercialization, making it a valuable partner for startups in the health tech sector.
Valitas Ventures invests in health technology companies, particularly those transitioning from development to commercial stages. The firm focuses on North American and European markets, seeking opportunities in companies that have not fully realized their commercial potential or are nearing the end of their investment period without achieving maturity. This approach allows Valitas to identify firms that require additional support to reach their market potential.
The investment strategy emphasizes companies that have completed scientific feasibility and are in advanced regulatory phases. Valitas Ventures employs a unique model designed to facilitate rapid transitions from development to commercialization, enhancing the value of its portfolio through strategic collaborations and reimbursement-code capabilities. This focus on health technology, including medical devices and digital health, positions Valitas as a specialist investor in a critical sector.
Valitas Ventures has a focused portfolio in the health technology sector, which includes:
These companies exemplify Valitas's commitment to investing in firms that are transitioning from development to commercialization, particularly those that have completed scientific feasibility and are in advanced regulatory phases.
Yaron Itzhari - Founding Partner. Yaron has a background as the Country Manager of Medtronic Israel, bringing extensive experience in health technology investments.
Tal Shnider - Co-Founder. Tal has prior experience in market access and reimbursement at Medtronic, aligning with Valitas's focus on commercialization.
Yehuda Gur - Investment Committee Member. Yehuda previously served as VP of Strategy & Chief of Staff at Hinoman and is involved in Valitas Ventures' investment decisions.
To pitch Valitas Ventures, founders should submit their proposals through the official website. It is essential to include a comprehensive pitch deck that outlines the technology, market opportunity, and regulatory status.
Valitas Ventures prefers detailed information about the startup's commercialization strategy and potential for growth. While specific response times are not disclosed, founders should expect a thorough review process.
In January 2025, Valitas Ventures participated in a $30 million Series A funding round for FIZE Medical, a company focused on fluid-management optimization. This investment highlights Valitas's commitment to supporting health technology firms transitioning to commercialization.
Valitas Ventures continues to expand its portfolio in the health technology sector, with a focus on companies that have completed scientific feasibility and are in advanced regulatory phases.
What are Valitas Ventures' investment criteria?
Valitas Ventures focuses on health technology companies that have completed scientific feasibility and are in advanced regulatory phases. They seek firms transitioning from development to commercialization, particularly in North America and Europe.
How can I pitch to Valitas Ventures?
Founders can pitch their companies through the Valitas Ventures website. It is recommended to include detailed information about the technology, market potential, and regulatory status in the pitch deck.
What makes Valitas Ventures different from other investors?
Valitas Ventures specializes in health technology investments and leverages the strengths of the Israeli healthcare system to enhance portfolio value. Their unique model facilitates rapid transitions from development to commercialization.
What is the geographic focus of Valitas Ventures?
Valitas Ventures primarily targets companies in North America and Europe, with a strong emphasis on health technology sectors.
What is the typical check size for investments?
Specific check sizes have not been disclosed publicly, but Valitas Ventures invests in companies at various stages, including Series A and Series B.
What kind of support do portfolio companies receive?
Valitas Ventures adds value through expertise in commercialization, strategic collaborations, and reimbursement-code capabilities, facilitating rapid market entry and growth for its portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.